About this trial
The goal of this clinical trial is to learn if quantitative measurement of brain and neurofeedback intervention techniques works to prevent perioperative neurocognitive deficits in elderly oncology patients who are to undergo elective major surgery. The main questions it aims to answer are:
* Can neurofeedback intervention training reduce the incidence of postoperative delirium in elderly oncology patients? Researchers will compare the incidence of postoperative delirium in elderly oncology patients after training in neurofeedback intervention with those after living a normal life, to see if training in neurofeedback intervention before surgery is effective in preventing the development of postoperative delirium.
Participants will:
* Take neurocognitive feedback intervention training for 14 days prior to surgery (recommended to be used for at least 1 hour per day for a cumulative preoperative use of 14 hours).
* Received preoperative and postoperative assessments of cognitive function by a third-party researcher, as well as daily delirium assessments for 7 days postoperatively.
* The subjects in the control group lived a normal life every day before the operation, and the rest of the measures were the same as those in the intervention group.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing elective major surgery (colorectal, pancreatic-gastric, hepatobiliary, thoracic, gynaecological and urological) under general anaesthesia;
Expected duration of surgery >2 hours;
Age ≥65 years;
Disqualifiers
refused to participate in this study;
preoperative MMSE score <26 or if the patient's educational level was lower than high school, MMSE <24 and active depressive state (GDS-15 score >9);
underwent neurosurgery or the surgery itself interfered with the patient's postoperative communicative communication (e.g., tracheotomy);
severe organ dysfunction;
Trial design
Parallel
Treatments tested in this trial
neurofeedback intervention training game
Combination product1. Issuance of training equipment and training in its use: For subjects randomly assigned to the intervention group, a volunteer who has received adequate training in the use of the equipment will issue the EEG monitoring electrodes (model: HXD-1) and paired PADs, and will provide an activated account for the use of the subject only and training in its use. Subjects will be provided with a short tutorial on how to use the APP, which is very user-friendly and suitable for elderly novices. An initial training session will consist of 3 training components and will be completed with a volunteer. 2. Training programme and supervision: The closed-loop neurofeedback training will consist of 3 parts, namely "Digital Meditation", "Brain Training" and "Sleep Induction". The "brain training" will consist of three games: "Idea Chase", "Idea Magic Ball" and "Focused Archery". The control subjects lived a normal life before the surgery, and all subjects underwent the surgery as planned.
Treatment groups
Trial outcomes
Primary outcomes
Incidence of postoperative delirium
On postoperative days 1-7, the investigator assessed subjects for CAM daily from 8:00 am-12:00 pm and 14:00 pm-18:00 pm.
Secondary outcomes
Number of occurrences of delirium
Researchers recorded the number of times subjects experienced delirium in the 7 days following surgery.
Severity of POD
For subjects diagnosed with postoperative delirium within 7 days of surgery, the severity of delirium was assessed using Confusion Assessment Method-Severity Short Form. This scale includes a total of 4 items, with a scoring range of 0-7 points, where 0 points indicate no delirium, 1 point indicates mild delirium, 2 points indicate moderate delirium, and 3-7 points indicate severe delirium.
Type of POD
For subjects diagnosed with postoperative delirium within 7 days after surgery, the type of delirium is determined based on their presentation. Hyperactive delirium is characterized by alertness, agitation, and increased psychomotor activity; hypoactive delirium is characterized by apathy, drowsiness, and reduced psychomotor activity; mixed delirium is characterized by alternating features of hyperactivity and hypoactivity.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: